Common Equity: The sum of all common equity items.
vTv Therapeutics Inc. (VTVT) had Common Equity of $78.63M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-13.05M |
|
-- |
|
-- |
|
$13.93M |
|
$-13.93M |
|
$0.88M |
|
$-13.05M |
|
$-13.05M |
|
$-13.05M |
|
$-13.05M |
|
$-13.05M |
|
$-13.05M |
|
$-13.93M |
|
$-13.93M |
|
12.41M |
|
12.41M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$87.59M |
|
-- |
|
$0.00M |
|
$87.59M |
|
$7.02M |
|
-- |
|
$1.94M |
|
$8.96M |
|
|
Common Equity |
$78.63M |
$78.63M |
|
$78.63M |
|
3.94M |
|
| Cash Flow Statement Financials | |
$-2.29M |
|
-- |
|
-- |
|
$88.93M |
|
$86.64M |
|
$-2.29M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.60% |
|
-16.60% |
|
-14.90% |
|
-16.60% |
|
$19.96 |
|
$-0.18 |
|
$-0.18 |
|